Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.

Lee J, Seol MY, Jeong S, Lee CR, Ku CR, Kang SW, Jeong JJ, Shin DY, Nam KH, Lee EJ, Chung WY, Jo YS.

Medicine (Baltimore). 2015 Jan;94(2):e380. doi: 10.1097/MD.0000000000000380. Erratum in: Medicine (Baltimore). 2015 Feb;94(8):1. Medicine (Baltimore). 2015 Feb;94(8):1.

2.

Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.

Zhang XJ, Su YR, Liu D, Xu DB, Zeng MS, Chen WK.

J Surg Res. 2014 Dec;192(2):487-93. doi: 10.1016/j.jss.2014.05.066. Epub 2014 May 27.

PMID:
24974154
3.

KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.

Lee J, Seol MY, Jeong S, Kwon HJ, Lee CR, Ku CR, Kang SW, Jeong JJ, Shin DY, Nam KH, Lee EJ, Chung WY, Jo YS.

J Mol Endocrinol. 2015 Apr;54(2):115-24. doi: 10.1530/JME-14-0270. Epub 2015 Jan 21.

PMID:
25608512
4.

Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.

Wu G, Zhou Y, Li T, Guo J, Zhou Z.

J Int Med Res. 2013 Jun;41(3):816-24. doi: 10.1177/0300060513481923. Epub 2013 May 17.

PMID:
23685894
5.

Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.

Wang N, Jiang R, Yang JY, Tang C, Yang L, Xu M, Jiang QF, Liu ZM.

J Mol Histol. 2014 Aug;45(4):391-9. doi: 10.1007/s10735-013-9557-9. Epub 2013 Nov 26.

PMID:
24276590
6.

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.

Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C.

BMC Genomics. 2015 Oct 21;16:828. doi: 10.1186/s12864-015-2082-3.

7.

MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers.

Mutalib NS, Yusof AM, Mokhtar NM, Harun R, Muhammad R, Jamal R.

Asian Pac J Cancer Prev. 2016;17(1):25-35. Review.

8.

GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.

Lee J, Jeong S, Lee CR, Ku CR, Kang SW, Jeong JJ, Nam KH, Shin DY, Chung WY, Lee EJ, Jo YS.

Medicine (Baltimore). 2015 Jun;94(25):e998. doi: 10.1097/MD.0000000000000998.

9.

Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.

Kim WW, Yang SI, Kim JH, Choi YS, Park YH, Kwon SK.

World J Surg Oncol. 2012 Oct 30;10:226. doi: 10.1186/1477-7819-10-226.

10.

Papillary thyroid carcinoma involving cervical neck lymph nodes: correlations with lymphangiogenesis and ultrasound features.

Choi Y, Park KJ, Ryu S, Kim DH, Yun J, Kang DK, Chun M.

Endocr J. 2012;59(10):941-8. Epub 2012 Jun 22.

11.

The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.

Salajegheh A, Dolan-Evans E, Sullivan E, Irani S, Rahman MA, Vosgha H, Gopalan V, Smith RA, Lam AK.

Exp Mol Pathol. 2014 Apr;96(2):212-8. doi: 10.1016/j.yexmp.2014.02.003. Epub 2014 Feb 12.

PMID:
24530443
12.

Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.

Wang N, Luo HJ, Yin GB, Dong CR, Xu M, Chen GG, Liu ZM.

Clin Dev Immunol. 2013;2013:589423. doi: 10.1155/2013/589423. Epub 2013 Oct 29.

13.

[High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].

Yue C, Zhao X, Tian C, Jin Y, Liu H.

Zhonghua Bing Li Xue Za Zhi. 2015 Jul;44(7):490-4. Chinese.

PMID:
26705040
14.

Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.

Fisher KE, Jani JC, Fisher SB, Foulks C, Hill CE, Weber CJ, Cohen C, Sharma J.

J Surg Res. 2013 Nov;185(1):217-24. doi: 10.1016/j.jss.2013.05.003. Epub 2013 May 23.

15.

Differential protein expression of lymph node metastases of papillary thyroid carcinoma harboring the BRAF mutation.

Park WS, Chung KW, Young MS, Kim SK, Lee YJ, Lee EK.

Anticancer Res. 2013 Oct;33(10):4357-64.

PMID:
24123003
16.

Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.

Salajegheh A, Pakneshan S, Rahman A, Dolan-Evans E, Zhang S, Kwong E, Gopalan V, Lo CY, Smith RA, Lam AK.

Hum Pathol. 2013 Oct;44(10):2204-12. doi: 10.1016/j.humpath.2013.04.014. Epub 2013 Jul 8.

PMID:
23845470
17.

Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.

Wang N, Dong CR, Jiang R, Tang C, Yang L, Jiang QF, Chen GG, Liu ZM.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):322-30. eCollection 2014.

18.

[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].

Jiang XL, Zhang H, Chen YL, Peng L.

Zhonghua Bing Li Xue Za Zhi. 2017 Mar 8;46(3):160-165. doi: 10.3760/cma.j.issn.0529-5807.2017.03.004. Chinese.

PMID:
28297755
19.

NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells.

Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W.

Oncotarget. 2017 Jan 10;8(2):2293-2306. doi: 10.18632/oncotarget.13725.

20.

Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.

Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG.

Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26.

PMID:
27574773

Supplemental Content

Support Center